Allegra Orthopaedics Ltd (ASX: AMT) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Allegra Orthopaedics Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $15.67 million
P/E Ratio N/A
Dividend Yield N/A
Shares Outstanding 104.46 million
Earnings per share -0.005
Dividend per share N/A
Year To Date Return -58.57%
Earnings Yield N/A
Franking N/A
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

Allegra Orthopaedics Ltd (ASX: AMT)
Latest News

AMT ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Allegra Orthopaedics Ltd

Allegra Orthopaedics Ltd is engaged in the research, product development, and manufacturing of medical devices including prosthetic implant tools. It offers adult and adolescent clavicle fixation systems and pins; shoulder implants; hand fracture plates and ulna heads, compression screws, distal radius systems, and hand fracture systems; hip stems and heads, CSF cups, and evolution and resurfacing hip products; and knee replacement systems among others. It operates in two segments Orthopaedics Division, which derives majority revenue sells and distributes its portfolio of medical device products. Innovation Division which invests resources into the development and commercialization of new products to take to market.

AMT Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
02 Dec 2021 $0.15 $0.01 6.90% 33 $0.15 $0.15 $0.15
01 Dec 2021 $0.15 $-0.01 -6.45% 60,439 $0.16 $0.16 $0.15
30 Nov 2021 $0.16 $-0.02 -11.76% 16,193 $0.16 $0.16 $0.15
29 Nov 2021 $0.17 $-0.01 -5.56% 15,223 $0.17 $0.17 $0.17
26 Nov 2021 $0.18 $0.01 5.88% 20,561 $0.18 $0.18 $0.18
23 Nov 2021 $0.17 $0.00 0.00% 29,323 $0.17 $0.17 $0.17
22 Nov 2021 $0.18 $-0.02 -10.26% 16,558 $0.19 $0.19 $0.18
19 Nov 2021 $0.20 $-0.01 -5.00% 3,058 $0.20 $0.20 $0.20
18 Nov 2021 $0.20 $0.00 0.00% 5,004 $0.20 $0.20 $0.20
16 Nov 2021 $0.21 $0.00 0.00% 712 $0.21 $0.21 $0.21
15 Nov 2021 $0.20 $-0.01 -4.76% 241 $0.20 $0.20 $0.20
11 Nov 2021 $0.21 $0.02 10.26% 4,930 $0.20 $0.21 $0.20
10 Nov 2021 $0.20 $-0.01 -5.00% 788 $0.20 $0.20 $0.20

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Anthony (Tony) Geoffrey Hartnell Non-Executive Director Nov 2014
Mr Hartnell has career in both government and private practice. He is a founding partner of Atanaskovic Hartnell. He was the inaugural Chairman of the Australian Securities Commission. He has chaired a number of ASX-listed companies. He is Director of Parnell Pharmaceuticals Holdings Limited, Molopo Energy Limited and Aurora Funds Management Limited. He is Chair of Risk Committee.
Mr Peter Kazacos Non-Executive DirectorNon-Executive Chairman May 2006
Mr Kazacos has over 40 years' experience in the IT industry. He also founded Anittel Ltd. Prior to founding KAZ and Anittel, Peter held a number of senior technical positions in the Australian IT industry with Australian organisations. He is Member of Risk Committee.
Mr Sean St Clair Mulhearn Non-Executive Director Nov 2015
Mr Mulhearn has been involved in the financial markets for over 30 years' with experience in Asia, Europe and the Americas. Sean has experience in risk management. He founded Jacaranda Capital Partners. He is Member of Risk Committee.
Dr Nicholas Hartnell Non-Executive Director Mar 2018
Dr Hartnell has many years of experience in Orthopaedic care. Nicholas set up his practice in Bowral in the Southern Highlands, NSW and has since expanded his surgical practice into the Goulburn, and Camden/Campbellt own areas. As a result of Nicholas' experience as an orthopaedic surgeon, he will continue in his role as a member of Allegra's Panel of Surgeon Advisers.
Mr Justyn Peter Stedwell Company Secretary Jan 2017
-
Ms Jenny Swain Chief Executive Officer May 2016
-
Jenny Swain Chief Executive Officer
-
Justyn Peter Stedwell Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Robinwood Investments Pty Ltd 38,274,948 38.44%
Netwealth Investments Limited (Wrap Services Nc) 9,169,579 9.21%
Welsh Superannuation Pty Limited 6,600,000 6.63%
Marie Caroll & Dawson Caroll 5,636,285 5.66%
J P Morgan Nominees Australia Pty Limited 4,959,813 4.98%
The University Of Sydney 4,806,000 4.83%
Dr Andrew William Leicester & Mrs Skye Christine Leicester (Leicester Super Fund A/C) 3,353,123 3.37%
Dugal Diagnostics Pty Ltd (The Dugal Family) 3,000,000 3.01%
4 Holes In One Pty Ltd (Number 5) 3,000,000 3.01%
Dr Andrew William Leicester & Mrs Skye Christine Leicester 2,272,270 2.28%
Chew Investments Pty Ltd (Chew Investments) 1,333,333 1.34%
Mr Nicholas Hartnell 1,224,090 1.23%
Mergin Investments Pty Ltd (M & V Cross Super Fund Nc) 1,198,000 1.20%
Mr Thomas James Carroll 1,000,000 1.00%
Mr Kenneth Campbell 1,000,000 1.00%
Sanperez Pty Ltd (P Chalmers Partnership A/C) 971,000 0.98%
Destin Pty Limited 946,470 0.95%
Misty Hills Nominees Pty Ltd 892,857 0.90%
Mr Fenton Paul Healy (Cheeky Monkey Nc) 550,000 0.55%
Desmond J Bokor Pty Limited (Kooringa Super Fund A/C) 510,000 0.51%

Profile

since

Note